Cross-linked sodium hyaluronate matrix (CL-HA) (CL-HA)

Cross-linked sodium hyaluronate matrix (CL-HA) is a biocompatible, biodegradable polymer derived from hyaluronic acid, a naturally occurring glycosaminoglycan found in the extracellular matrix of connective tissues (StatPearls, 2023). Through chemical cross-linking, typically using agents like 1,4-butanediol diglycidyl ether (BDDE), the linear chains of sodium hyaluronate are transformed into a three-dimensional network that is significantly more resistant to enzymatic degradation by hyaluronidases and mechanical breakdown compared to non-cross-linked forms (PubChem, CID 24847751). This matrix serves primarily as a therapeutic agent or medical device rather than a traditional biological target such as a receptor or enzyme. In clinical practice, it is extensively utilized for viscosupplementation in osteoarthritis to restore the lubricating and shock-absorbing properties of synovial fluid (NIH, 2022). Additionally, it is a cornerstone of aesthetic medicine, where it is used as a dermal filler to provide structural support, hydration, and volume restoration in the skin (Journal of Clinical and Aesthetic Dermatology, 2015). While its primary action is mechanical, the matrix can interact with cell surface receptors like CD44, potentially modulating inflammatory responses and tissue regeneration (Matrix Biology, 2019). It is also employed in ophthalmic surgery as a viscoelastic agent to protect corneal endothelium and maintain anterior chamber depth (Mayo Clinic, 2023).

Other names

HylanCross-linked hyaluronic acidHyaluronan matrixHylan G-F 20Sodium hyaluronate gel

Viscosupplementation and mechanical cushioning through the restoration of synovial fluid rheology and physical volume replacement in soft tissues (StatPearls, 2023).